ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

An 8-Gene Expression Assay in Peripheral Blood for Diagnosis of Antibody-Mediated Rejection after Kidney Transplantation

E. Van Loon1, S. Gazut2, S. Yazdani1, E. Lerut1, H. de Loor1, M. Coemans1, L. Noël3, L. Thorrez1, L. Van Lommel1, F. Schuit1, D. Lambrechts1, T. Van Brussel1, B. Sprangers1, D. Kuypers1, M. Essig4, W. Gwinner5, D. Anglicheau6, P. Marquet7, M. Naesens1

1Catholic University Leuven, Leuven, Belgium, 2CEA, Gif-sur-Yvette, France, 3Necker-Enfants Malades Institute, Paris, France, 4CHU Limoges, Limoges, France, 5Hannover Medical School, Hannover, Germany, 6Paris Descartes, Sorbonne Paris Cité University, Paris, France, 7RTRS Centaure, Necker Hospital, Paris, France

Meeting: 2019 American Transplant Congress

Abstract number: 54

Keywords: Area-under-curve (AUC), Gene expression, Non-invasive diagnosis, Rejection

Session Information

Date: Sunday, June 2, 2019

Session Name: Concurrent Session: Biomarkers, Immune Monitoring and Outcomes I

Session Time: 2:30pm-4:00pm

 Presentation Time: 2:30pm-2:42pm

Location: Room 306

Related Abstracts
  • Validation Study of Gene Expression Signatures Associated with Antibody-Mediated Rejection (ABMR) and Cell-Mediated Rejection (CMR) in Renal Allograft Biopsies (Bx) Suggests Complexity of Molecular Diagnosis for ABMR Compared to CMR
  • Validation of a Peripheral Blood Gene Expression Profile for SubClinical Acute Rejection in Kidney Transplant Recipients – Findings from the CTOT 08 Study

*Purpose: Antibody-mediated rejection is a leading cause of graft failure after kidney transplantation. The diagnosis of antibody-mediated rejection is made by combining assessment of circulating antibodies with histological assessment of invasive allograft biopsies. Non-invasive biomarkers with sufficient diagnostic accuracy are not available. We sought to identify and validate a blood biomarker for non-invasive detection of antibody-mediated rejection.

*Methods: In this multicentre study, peripheral blood samples were prospectively collected from June 2011 to August 2016 at time of renal allograft biopsies, and then analysed in three phases, following a case-control design (discovery and derivation phase, N=117 and N=183 respectively) and a trans-sectional study for performance assessment (independent validation phase, N=387). Untargeted screening of whole genome transcriptomics was performed for the discovery phase and targeted mRNA expression analysis for the derivation and validation phases.

*Results: In the discovery and derivation phases, we developed and locked a multigene assay of 8 genes in peripheral blood that discriminated cases with (N=49) from cases without (N=134) antibody-mediated rejection (diagnostic accuracy in derivation cohort, 78.1% (95% CI, 70.7 to 85.6, p<0.001). In the independent validation cohort, this 8-gene marker discriminated cases with (N=41) from cases without antibody-mediated rejection (N=346) with similar accuracy (79.9%; 95% CI, 72.6 to 87.2, p<0.001). At the optimal cut-off the marker held a sensitivity of 80.5%, specificity of 71.4%, PPV of 25.0% and NPV of 96.9%.

*Conclusions: We developed and validated a novel 8-gene expression assay in peripheral blood that can be used for non-invasive diagnosis of antibody-mediated rejection of kidney allografts.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Loon EVan, Gazut S, Yazdani S, Lerut E, Loor Hde, Coemans M, Noël L, Thorrez L, Lommel LVan, Schuit F, Lambrechts D, Brussel TVan, Sprangers B, Kuypers D, Essig M, Gwinner W, Anglicheau D, Marquet P, Naesens M. An 8-Gene Expression Assay in Peripheral Blood for Diagnosis of Antibody-Mediated Rejection after Kidney Transplantation [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/an-8-gene-expression-assay-in-peripheral-blood-for-diagnosis-of-antibody-mediated-rejection-after-kidney-transplantation/. Accessed December 6, 2019.

« Back to 2019 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Penis Transplantation: First U.S. Experience.
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
  • Penis Transplantation: First U.S. Experience.
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
  • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2019 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

wiley-new-logo

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.